Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
Background and objectivesWhile randomized, controlled trials (RCTs) are the gold standard for determining treatment efficacy, they do not capture the effectiveness of treatment during real-world use. We aimed to evaluate the association between demographics and multiple sclerosis (MS) disease-modify...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2023-09-01
|
| Collection: | Frontiers in Neurology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1243589/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|